Clinical Trial

A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn if regular use of Provox® ActiValve® by patients after a total laryngectomy with TEP can decrease the number of VP device replacements needed annually.
Trial Details
NCT Number NCT07369050
Lead Sponsor M.D. Anderson Cancer Center
Conditions Laryngectomy
Enrollment 48 participants
Start Date 2026-07-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-27